| Full Name | Jemima Pokuaa |
|---|---|
| Gender | Female |
| Speciality | Speech-language Pathologist |
| Location | 200 Tyre Ave, Newark, Delaware |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1205159407 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 235Z00000X | Speech-language Pathologist | O1-0001143 (Delaware) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Jemima Pokuaa, 200 Tyre Ave, Newark, DE 19711-7136 Ph: (302) 454-2047 | Jemima Pokuaa, 200 Tyre Ave, Newark, DE 19711-7136 Ph: (302) 454-2047 |
News Archive
A new study suggests that people with muscle diseases such as muscular dystrophies may benefit more from group doctor visits than individual appointments. The study is published in the June 18, 2014, online issue of Neurology®, the medical journal of the American Academy of Neurology.
A team of researchers from Center for Biomedical Technology at Universidad Politécnica de Madrid has developed a pocket instrument capable of perceiving radio signals from 50 MHz to 6 MHz and storing this information in a non-volatile memory. After collecting and storing the information, the system assesses the daily exposure of a person to electromagnetic radiation.
The American Cancer society's pages on breast cancer in men lay out the facts. About 2,000 men are diagnosed with breast cancer each year, which makes it rare: about 100 times more women get the disease. It is known that men, like women, are more likely to develop cancer if they have certain mutations of the BRCA1 and BRCA2 genes. Family history and age contribute to a man's likelihood of developing the disease as well.
BioSpecifics Technologies Corp., a biopharmaceutical company developing first in class collagenase-based products, today announced that The Journal of Hand Surgery (JHS) has published in its December 2010 online edition pivotal CORD II phase III clinical trial of XIAFLEX (collagenase clostridium histolyticum), a novel, first-in-class biologic, conducted by BioSpecifics' strategic partner Auxilium Pharmaceuticals Inc., for the nonsurgical treatment of adult Dupuytren's contracture patients with a palpable cord.
› Verified 8 days ago
Kate Gordon, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 144 Brennen Dr, Newark, DE 19713 Phone: 302-292-6021 | |
Emily Randolph, MS CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 630 E Chestnut Hill Rd, Newark, DE 19713 Phone: 302-454-2301 | |
Susan Johnson, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 200 Tyre Ave, Newark, DE 19711 Phone: 302-454-2047 Fax: 302-454-5442 | |
Mary Elizabeth Clarke, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 3 Travertine Way, Newark, DE 19702 Phone: 302-241-5961 | |
Tatiana Guile, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 200 Tyre Ave, Newark, DE 19711 Phone: 302-454-2047 Fax: 302-454-5444 | |
Marielle Schank, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 200 Tyre Ave, Newark, DE 19711 Phone: 302-454-2047 Fax: 302-454-5442 | |
Christopher Apfelbach, MS, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 540 S College Ave Ste 102, Newark, DE 19713 Phone: 302-831-7100 |